A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer

BACKGROUND: The aim of this prospective, pilot, single‐arm phase II trial was to evaluate the safety and efficacy of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer (ES‐SCLC). METHODS: This phase II study was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Liao, Jiatao, Wu, Xianghua, Zhao, Xinmin, Sun, Si, Wang, Huijie, Hu, Zhihuang, Zhang, Yao, Yu, Hui, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108065/
https://www.ncbi.nlm.nih.gov/pubmed/35388976
http://dx.doi.org/10.1111/1759-7714.14414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108065/
https://www.ncbi.nlm.nih.gov/pubmed/35388976
http://dx.doi.org/10.1111/1759-7714.14414

Ejemplares similares